Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-04-24 @ 11:00 AM
Study NCT ID:
NCT02823405
Status:
COMPLETED
Last Update Posted:
2020-07-07
First Post:
2016-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
Sponsor:
X4 Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-15
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-01
First Submit QC Date:
None
Study First Post Date:
2016-07-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-01
Last Update Post Date:
2020-07-07
Last Update Post Date Type:
ACTUAL